Trial Profile
Clinical data over 24 months with dapagliflozin treatment for type 2 diabetes patients in our hospital
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Jan 2020
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 16 Aug 2017 New trial record